Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

Part of paid clinical trials in Bethesda, Maryland.

Sponsor
National Cancer Institute (NCI)
Study ID
NCT00019539
Phase
PHASE2
Status
Completed

Conditions

  • Recurrent Renal Cell Cancer
  • Stage IV Renal Cell Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them. PURPOSE: Randomized phase II trial to determine the effectiveness of monoclonal antibody therapy in treating patients who have advanced kidney cancer that cannot be surgically removed.

Key Dates

First listed
Jan 13, 2009
Start date
Nov 30, 1998
Status verified
Feb 2024
Completion
Nov 30, 2004

Study Design

Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
Surgery BranchBethesdaMaryland20892-

Find similar trials in Bethesda, MD

By research site
Surgery Branch· Bethesda, MD

Related Studies